Exscientia Appoints Georgy Egorov as CFOExscientia, a company in Artificial Intelligence (AI)-driven drug discovery, has announced the appointment of Mr Georgy Egorov as Chief Financial Officer (CFO). more ➔
Pfizer CEO announces SuccessionPfizer Inc. today announced its Board of Directors has unanimously elected Dr. Albert Bourla, 56, Pfizer Chief Operating Officer (COO), to succeed Ian Read as CEO effective January 1, 2019. Ian Read … more ➔
Ysios Capital appoints Guillem LaportaYsios Capital, a biotechnology venture capital firm in Spain, today announced that it has appointed Guillem Laporta as Principal. more ➔
Virion Appoints Vanessa King as President...Virion Biotherapeutics announced the appointments of Vanessa King, PhD, as President & Chief Executive Officer this week. more ➔
Carl Bjartmar appointed as CMO for Ascelia... Ascelia Pharma announced on Friday Spetember 14 that Carl Bjartmar, MD, PhD, has been appointed as new Chief Medical Officer (CMO) for Ascelia Pharma. Carl has most recently worked as CMO for Wilson … more ➔
Torbjørn Furuseth joins Targovax as CFOTargovax ASA (Targovax or the Company; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, announces the appointment of Dr. Torbjørn … more ➔
Johanna Ivaska joins Orion CorporationJohanna Ivaska, Academy Professor of Biochemistry has been appointed Head & Vice President of Oncology Research in Orion Corporation as of 1 October 2018. Ivaska joins Orion from the University … more ➔
F-star Appoints Nessan Bermingham as Chair...F-star, a biopharmaceutical company developing novel bispecific antibodies, today announces the appointment of Nessan Bermingham, Ph.D. as Chairman of its Board of Directors. Nessan succeeds John Edwards … more ➔
Crescendo Biologics appoints new CMOCrescendo Biologics Ltd (Crescendo), today announced that Pavel Pisa, MD, PhD, has been appointed as Chief Medical Officer of the Company with immediate effect. more ➔
Changes at Arix BioscienceArix Bioscience, a healthcare and life science company, today announces planned changes to its executive team to prepare for its next phase of growth and development. Dr Joe Anderson, who has served … more ➔